Abel Hall LLC
MDGL icon

Abel Hall LLC’s Madrigal Pharmaceuticals MDGL Stock Holding History

Abel Hall LLC’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$648K Sell
1,286
-103
-7% -$54.4K 0.12% 148
2026
Q2 		$746K Buy
1,389
+118
+9% +$60.4K 0.13% 130
2026
Q1 		$665K Buy
1,271
+561
+79% +$268K 0.14% 126
2025
Q4 		$413K Buy
710
+120
+20% +$61.3K 0.1% 221
2025
Q3 		$271K Buy
+590
New +$220K 0.11% 196

Other funds holding MDGL

EULAV Asset Management
EULAV Asset Management Sarasota, Florida $2.77B AUM 18.47% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Bourgeon Capital Management
Bourgeon Capital Management Darien, Connecticut $696M AUM 39.92% 1-Year Est. Return
Shikiar Asset Management
Shikiar Asset Management New York $398M AUM 33.64% 1-Year Est. Return
Stanley-Laman Group
Stanley-Laman Group Berwyn, Pennsylvania $915M AUM 50.26% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Mutual of America Capital Management
Mutual of America Capital Management New York $10.1B AUM 33.74% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
BI Asset Management Fondsmaeglerselskab
BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $13.1B AUM 35.37% 1-Year Est. Return

Abel Hall LLC's MDGL Position: Q3 2026 in Review

Abel Hall LLC reduced its Madrigal Pharmaceuticals (MDGL) stake by 7.4% in Q3 2026, selling an estimated $54.4K and leaving 1,286 shares worth $648K. The position accounts for 0.12% of the portfolio, ranked #148.

Abel Hall LLC first reported a position in MDGL in Q3 2025 and has held it in 5 quarters since. The position peaked at $746K in Q2 2026. 84 funds tracked by Wall St. Rank hold MDGL as of Q3 2026.

  • Abel Hall LLC held 1,286 shares of Madrigal Pharmaceuticals worth $648K as of Q3 2026.
  • Abel Hall LLC sold 103 Madrigal Pharmaceuticals shares in Q3 2026, an estimated $54.4K.
  • Madrigal Pharmaceuticals made up 0.12% of Abel Hall LLC's portfolio in Q3 2026, its #148 holding.
  • Abel Hall LLC first reported a position in Madrigal Pharmaceuticals in Q3 2025 and has held it in 5 quarters since.
  • Abel Hall LLC's Madrigal Pharmaceuticals position peaked at $746K in Q2 2026.
  • 84 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q3 2026.

Based on Abel Hall LLC's 13F filing for Q3 2026, filed 19 Oct 2026.